Cargando…
MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis
OBJECTIVE: Although the role of microRNA-17 (miR-17) has been identified as a tumour biomarker in various studies, its prognostic value in cancers remains unclear. Therefore, we performed a systematic review and meta-analysis to analyse and summarise the relationship between the miR-17 status and cl...
Autores principales: | Huang, Chengzhi, Yu, Mengya, Yao, Xueqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988052/ https://www.ncbi.nlm.nih.gov/pubmed/29858404 http://dx.doi.org/10.1136/bmjopen-2017-018070 |
Ejemplares similares
-
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009) -
Serum exosomal microRNA‐766‐3p expression is associated with poor prognosis of esophageal squamous cell carcinoma
por: Liu, Shuang, et al.
Publicado: (2020) -
Correction: MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis
Publicado: (2018) -
MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1
por: Huang, Chengzhi, et al.
Publicado: (2019) -
MicroRNA expression profiling in male and female familial breast cancer
por: Pinto, R, et al.
Publicado: (2014)